1,088 followers
@DrMiguelPerales @TaniaJain11 @CIBMTR Not an exact comparison EBMT study suggests similar outcomes for AML patients over 60 with two donor types, although only 2/3 haplo group received PTCY. US vs Europe 🤔 https://t.co/6NliHP8vOI https://t.co/OAqLbVgf0V